3'-(4-morpholinyl)-3'-deaminodaunorubicin has been researched along with Adenocarcinoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Glazer, RI; Johnston, JB | 1 |
| Begleiter, A; Johnston, JB; Pugh, L | 1 |
2 other study(ies) available for 3'-(4-morpholinyl)-3'-deaminodaunorubicin and Adenocarcinoma
| Article | Year |
|---|---|
Pharmacological studies of 3'-(4-morpholinyl)-3'-deaminodaunorubicin in human colon carcinoma cells in vitro.
Topics: Adenocarcinoma; Antineoplastic Agents; Cell Survival; Colonic Neoplasms; Daunorubicin; DNA Replication; Doxorubicin; Humans; In Vitro Techniques; RNA; Time Factors | 1983 |
Cellular pharmacology of 3'-(3-cyano-4-morpholinyl)-3'-deaminoadriamycin and structural analogues in human colon carcinoma HT-29 cells in vitro.
Topics: Adenocarcinoma; Bacterial Proteins; Biological Transport; Cell Line; Cell Nucleus; Colonic Neoplasms; Daunorubicin; DNA Replication; Doxorubicin; Escherichia coli; Humans; RNA Polymerase I; Structure-Activity Relationship; Transcription, Genetic; Tumor Stem Cell Assay | 1987 |